Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Buffalo is a U.S. pet food company and brand focused on natural dog and cat food, treats, and nutritional products. The business was founded in 2003 and built around premium pet nutrition formulations marketed under the BLUE brand family. Blue Buffalo became a publicly traded company under the ticker BUFF before being acquired by General Mills in April 2018 for approximately $8.0 billion in enterprise value. Today it operates as a major pet food brand within General Mills, serving the companion animal nutrition market rather than human biopharma or healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Buffalo.